BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Clinical trials for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER explained in plain language.
Never miss a new study
Get alerted when new BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER trials appear
Sign up with your email to follow new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy takes on bladder cancer: new hope for High-Risk patients?
Disease control Not yet recruitingThis study tests a new treatment for high-risk bladder cancer that hasn't spread into the muscle. The treatment uses a modified virus (adenovirus) that is put directly into the bladder through a catheter. The goal is to see if the virus can kill cancer cells and prevent the cance…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New bladder cancer drug could help patients avoid surgery
Disease control Not yet recruitingThis phase 3 study tests a drug called NDV-01 in about 393 adults with non-muscle invasive bladder cancer. The drug is given directly into the bladder to help prevent the cancer from coming back or getting worse. The study includes people with intermediate-risk disease and those …
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Electric saline could zap bladder tumors before surgery
Disease control Not yet recruitingThis early study tests a new treatment called Plasma-Activated Saline Solution (PASS) for bladder cancer. Five patients will receive a one-week course of PASS infused directly into the bladder before their scheduled surgery. The goal is to see if the treatment safely shrinks tumo…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: EARLY_PHASE1 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Promising drug combo aims to keep bladder cancer from returning
Disease control Not yet recruitingThis study tests whether adding the drug disitamab vedotin to standard BCG therapy can help keep high-risk, early-stage bladder cancer from coming back. About 182 adults whose cancer has been surgically removed will receive either the combination or BCG alone. The main goal is to…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
New bladder cancer drug TARA-002 faces off against chemo in major trial
Disease control Not yet recruitingThis study tests a new drug called TARA-002 for people with a type of bladder cancer that hasn't spread into the muscle. About 284 adults will get either TARA-002 or standard chemotherapy. The goal is to see if TARA-002 works better at making the cancer disappear and is safe.
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Family video calls before surgery slash patient fear, study finds
Symptom relief Not yet recruitingThis study looks at whether a quick video call with a family member while waiting in the operating room can help lower stress, anxiety, and fear for people having bladder tumor surgery. About 124 adults will take part, with half getting the video call and half receiving standard …
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Phase: NA • Sponsor: Bitlis Eren University • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Bladder scope pain study: does age or gender matter?
Knowledge-focused Not yet recruitingThis study will enroll 150 adults having their first flexible cystoscopy (a thin tube to look inside the bladder) in an outpatient clinic. Researchers want to see if a person's age or sex changes how much pain they expect before the procedure versus how much they actually feel du…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: Kayseri Education and Research Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:03 UTC
-
Bladder surgery safety boost: new injury scale tested on 1,000 patients
Knowledge-focused Not yet recruitingThis study will test a new way to classify bladder injuries that happen during a common surgery for bladder tumors (TURBT). The goal is to better understand and manage these injuries to improve patient safety. About 1,000 adults having this surgery will take part, and researchers…
Matched conditions: BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC